Global shortage of ezetimibe/atorvastatin continues with expected supply date extended to end of March, while sertraline is in shortage until May

Atozet tablets, used for hypercholesterolaemia, are currently experiencing a shortage.

These include:

  • Atozet ezetimibe/atorvastatin 10mg/40mg tablet blister pack (From 30 Oct 2017 to 31 March 2018)
  • Atozet ezetimibe/atorvastatin 10mg/80mg tablet blister pack (From 30 Nov 2017 to 31 March 2018)
  • Atozet ezetimibe/atorvastatin 10mg/20mg tablet blister pack (From 30 Nov 2017 to 31 March 2018)
  • Atozet ezetimibe/atorvastatin 10mg/10mg tablet blister pack (From 30 Nov 2017 to 31 March 2018)

The composite packs in four different dosage strengths were originally predicted to be in shortage in Australia until end of January, however the expected date of supply has now been extended to 31 March.

MSD Australia has told AJP there is currently a global shortage due to manufacturing isuses.

The group says the shortage is not related to any quality issues.

Contact MSD for more information on (02) 8988 8000.

Other longstanding shortages include:

  • Bactroban mupirocin (as calcium) 20mg/g cream tube (From 12 Aug 2015 to 30 Nov 2018)
  • Bactroban mupirocin 2% nasal ointment tube (From 01 Jun 2017 to 31 Oct 2018)
  • Sertra 100 sertraline (as hydrochloride) 100mg tablet blister pack (From 19 Nov 2017 to 15 May 2018)
  • Sertra 50 sertraline (as hydrochloride) 50mg tablet blister pack (From 24 Oct 2017 to 15 May 2018)
  • Alprax 2 alprazolam 2mg tablet bottle (From 14 Dec 2017 to 1 May 2018)
  • DBL Papaverine Hydrochloride 30mg/1mL injection ampoule (From 2 Jan 2018 to 22 May 2018)
  • Dytrex 30 duloxetine (as hydrochloride) 30 mg enteric capsule blister pack (From 1 Jan 2018 to 30 Jan 2019)
  • Pharmacor duloxetine hydrochloride 60 mg enteric capsule blister pack (From 1 Jan 2018 to 30 Jan 2019)

See the Medicine Shortages Information Initiative for more information.